Understanding of how maternal thyroid inadequacy during early gestation poses a risk for developmental outcomes is still a challenge for the neuro-endocrine community. Early neocortical neurogenesis is accompanied by maternal thyroid hormone transfer to fetal brain, appearance of thyroid hormone receptors and absence of anti neurogenesis signals, followed by optimization of neuronal numbers through apoptosis. However, the effects of thyroid hormone (TH) deprivation on neurogenesis and neuronal cell death before the onset of fetal thyroid are still not clear. We show that maternal TH deficiency during early gestational period causes massive premature elevation in the expression of neuronal nitric oxide synthase (nNOS) with an associated neuronal death in embryonic rat neocortex. Maternal hypothyroidism was induced by feeding methimazole (0.025% w/v) in the drinking water to pregnant Sprague Dawley rats from embryonic day (ED) 6. Cerebral cortices from fetuses were harvested at different embryonic stages (ED14, ED16 and ED18) of hypothyroid and euthyroid group. Immunoblotting and Real-Time PCR results showed that both protein and RNA levels of nNOS were prematurely increased under maternal hypothyroidism and showed reversibility upon thyroxine administration. Immunohistochemistry revealed an increased nNOS immuno-reactivity in both the cortical plate and proliferative zone of neo-cortex along with a corroborative decrease in the Microtubule associated protein-2 (MAP-2) positive neurons under maternal TH insufficiency. Results combined, put forth nNOS as a novel target of maternal thyroid hormone action in embryonic neocortex and underscore the importance of prenatal screening and timely rectification of maternal thyroid hormone insufficiency even of a moderate degree.
Introduction
Endocrinologists are still equivocal about thyroid screening in early pregnancy and treatment in spite of associated IQ loss seen in offspring's of pregnant women with hypothyroidism (1) (2) (3) . The need for prevention of maternal thyroid hormone (TH) insufficiency before mid-pregnancy, however moderate, and whatever the underlying cause has been advocated (4) . Unfortunately, in spite of increasing evidences (5) (6) (7) (8) (9) (10) (11) that TH action in brain occurs much before the onset of fetal thyroid function, we know very little about the commencement of its molecular action during brain development. Whether and how TH deprivation affects the developmental process such as cortical neurogenesis and neuronal apoptosis which coincides with TH receptors (TRs) appearance (12) in brain is still not clear. Although TH insufficiency is known to be associated with defective expression of neuronal markers (8) , the reasons for the same are still not clear. Both neurogenesis and neuronal apoptotic mechanisms are tightly regulated to ensure optimization of neuronal number during the course of development (13) . One of the major players in this process is a neurotransmitter known as nitric oxide produced by an enzyme neuronal nitric oxide synthase (nNOS) expressed in newly generated neurons (13) . Though nNOS expression is modulated by steroid and thyroid hormones during postnatal development (14, 15) but it's modulation by TH during embryonic period lacks definite evidences. The present study has therefore been taken up to understand the effect of maternal thyroid hormone deficiency on the expression of nNOS and its consequent impact on generation and survival of neocortical neurons. We here uncover a novel role of maternal TH in repressing nNOS expression (an anti-neurogenic signal) during fetal neo-cortical development and proposes that its premature up-regulation even under moderate TH deficiency could have a detrimental bearing on fetal neurogenesis and neuronal survival during early gestation.
Materials and Methods

Animals and Treatments
Sprague Dawley rats were housed in a 12-h day and night cycle environment with ad libitum availability of chow diet and tap water. The pregnant rats were divided into two groups, euthyroid and hypothyroid (n = 20 in each group). 2-mercapto-1-methylimidazole (MMI) (0.025% wt/vol) was given to the pregnant rats in drinking water from gestational day 6 and continued until the animals were sacrificed. The day of visualization of spermatozoa in vaginal smears was designated as Embryonic day 0 (ED 0). Fetuses were separated on ice, fetal cortices quickly dissected, and 5-7 brains from each litter were pooled. Cortices from three different litters were used for immunoblotting and Realtime PCR analysis and three to four sections from three different litters were analyzed in each group for immunohistochemistry. Cerebral cortices were collected at Embryonic day 14 (ED14) (n =20), ED16 (n = 15), ED18 (n = 15). For replacement group (Hypothyroid+T4), pregnant dams on an MMI regimen were injected daily with T4 (1.5 μg/100 g body weight) s.c. from ED12-ED15 and fetal cortices were collected at ED16 (n =15). hypothyroxinemic model was prepared as described by Auso et al (4) , in brief MMI was administered to pregnant dams for 3 days from ED12-ED15 and fetal cortices were collected at ED16 (n=15). Total T4 (TT4) and total T3 (TT3) were measured in the serum of sacrificed dams by RIA using DPC kits (DPC, New York, NY). All animal procedures performed above were approved by the Institutional animal ethics committee as per International Guidelines for Animal Care and Research.
Western blotting
Cerebral cortices (in all groups) from three different litters were harvested at each developmental stage, snap-frozen in liquid nitrogen, and stored at -80ºC until further investigation. For preparation of tissue homogenates, cerebral cortices were washed once with PBS and suspended in 10 vols of lysis buffer [10 mM Tris-Cl (pH 7.5), 50 mM sodium chloride and 1% Triton-X-100 containing phenylmethylsulfonyl fluoride (1 mM) and protease inhibitor cocktail (a mixture of 4-(2-aminoethyl) benzenesulfonyl fluoride, pepstatinA, E-64, bestatin, leupeptin, and aprotinin (Sigma, St. Louis, MO)] and kept on ice for 10 min. Then the tissues were homogenized using a Teflon homogenizer and centrifuged at 12,000Xg for 15 min at 4 0 C, and the supernatant was collected. Protein concentration was determined in the above samples, in the tissue homogenate, using a protein assay kit (Bio-Rad, Hercules, CA). Tissue homogenate proteins (50-100 μg) were subjected to 6-12% SDS-PAGE and electrotransferred onto nitrocellulose membrane. The membranes were incubated with either antinNOS, anti-PCNA (Abcam, Denmark) or PARP (Cell signaling technology, MA) followed by incubation with horseradish peroxidaseconjugated secondary antibodies (Santa Cruz biotechnology, CA). The signals were detected using an enhanced chemiluminescence detection system (Amersham Biosciences, Little Chalfont, and UK). Relative expression of each protein was determined by densitometric analysis using LabWorks 4.0 software (UVP Ltd., Cambridge, UK).
RNA extraction and Real time PCR
Total RNA was isolated from the neocortex at ED16 (from both euthyroid and hypothyroid groups) from three different litters following single step RNA isolation method using TRIZOL reagent (MRC Inc., Cincinnati, OH). Total RNA (2 μg) was reverse transcribed to cDNA using oligo-(dT) 16 
Statistical analysis
Statistical analysis was performed by using SPSS software version 11 (SPSS, Inc., Chicago, IL). The data are presented as a mean ± SE. Significant differences between groups were compared by two-way ANOVA, factors being developmental stages and experimental groups (Euthyroid vs. Hypothyroid). One-way ANOVA was then used to identify developmental stages affected by the hypothyroidism, followed by Turkey's or Duncan post hoc test. P value <0.05 was considered statistically Significant.
Results
Maternal TH insufficiency during early embryonic periods results in premature and increased expression of nNOS in developing cerebral cortex
Pregnant Sprague-Dawley rats were rendered hypothyroid by administering MMI and their thyroidal status was assessed by RIA. Total circulating T3 and T4 concentrations in MMI-treated dams, at ED14, ED16 and ED18, were markedly reduced to less than 10 % of those of the euthyroid animals. This model was further validated by western blot analysis of Glial Fibrillary acidic protein (GFAP). As reported earlier (8) it is found to be down regulated under TH deficiency (Fig. 1A) . In fetal neocortices obtained from euthyroid dams, nNOS expression is prominently detectable on western blots only by embryonic day 18 (ED18) in agreement with earlier reports (17) (Fig. 1B) . However, its massive premature expression under hypothyroidism is seen as early as ED14 which remained elevated thereafter (Fig. 1B) . This increase in the protein level under hypothyroidism follows 37.3 x 10 3 fold increase in its RNA level (p<0.001) measured by sensitive real-time PCR analysis at ED16 . Since TH are known to regulate gene expression through nuclear receptors, we therefore looked into the status of their receptors under maternal TH deficiency. Interestingly, the increase in levels of nNOS correlated with 2.2 x 10 3 fold increase seen in the level of TR-α (p<0.001) that is known to be expressed early during development (12) . Relative spatial distribution of nNOS within the developing neocortex through immuno-histochemical staining at ED16 revealed its weak staining in the cortical plate (CP) and near absence in ventricular zone under euthyroid condition (17, 18) (Fig. 2A) . In contrast, we observed a significant (p<0.001) increase in the levels of nNOS positive cells both in the proliferative zone and prominently in the cortical plate of hypothyroid brain (Fig. 2B-D) . Similarly TR-α levels were also increased both in the proliferative zone and cortical plate under hypothyroidism (Fig. 2E,F) .
Increased nNOS expression correlates with decreased MAP-2 staining and increased cell death in the cortical plate under hypothyroidism Since nNOS is a negative regulator of neurogenesis (18, 19) and was up-regulated in the proliferative ventricular zone under maternal hypothyroidism, we next looked whether its increased expression associated with a defective neurogenesis under hypothyroidism. For this, we did immunohistochemistry with MAP-2 antibody (marker of differentiated neurons). Results showed a significant reduction in the number of MAP-2 positive cells in the cortical plate indicating reduced neurogenesis under hypothyroidism (Fig. 3A-C) . Moreover the reversibility of MAP-2 staining on T4 supplementation demonstrated a correspondence with nNOS expression (Fig. 3A-C & Fig. 4A) . Nitric oxide inhibitory action on neurogenesis could involve either reduction in the proliferative potential of neural precursor cells (NPCs) (17) or a compromised survival of newly generated neurons after differentiation (13) . To resolve this, we looked at the levels of PCNA (a proliferation marker) (Fig. 3C ) and cleaved PARP (an apoptotic marker) (Fig. 3D) . Results showed that maternal hypothyroidism does not alter proliferation of NPCs as indicated by PCNA levels. However, the cleavage of PARP was significantly increased under hypothyroidism. Since PARP cleavage is associated with increased neuronal death during development (20) these results provide evidence for increased cell death under TH deficiency which was also confirmed by TUNEL labeling (Fig. 3E,F) . However, the direct relationship suggested by strong association between nNOS and poor survival of newly born neurons under TH deprivation still need to be proved.
Decreased Maternal Thyroxine (T4) and not Tri-iodothyronine (T3) is associated with the up-regulated nNOS levels in developing cerebral cortex
Recent studies by Morreale de Escobar et al (3) have shown that most of the T3 available to the fetal brain before the onset of fetal thyroid function (around ED17.5) is derived from deiodination of maternal T4. Therefore to investigate the role of maternal T4/T3 alteration in regulating nNOS expression we employed a model of moderate and transient maternal TH deficiency or hypothyroxinemia as described by Auso et al (4) . Results revealed that even a moderate and transient decrease in maternal T4 (with T3 levels still within the normal range) increased nNOS expression significantly and this was reversible by T4 administration to hypothyroid pregnant dams (Fig. 4A) . Therefore our results support that the alterations in fetal brain are responsive to circulating maternal T4 and not T3.
Discussion
During early pregnancy, the fetus is totally dependent on maternal thyroid hormone for normal brain development. Adequate dietary intake of iodine during pregnancy is essential for maternal TH production and later for thyroid function in the fetus (1-3) . Several clinical studies in various countries have consistently documented a relationship between maternal thyroid deficiency during pregnancy and problems with neuropsychological development of the offspring (1, 2, 21-23). However molecular explanations for these clinical findings have only recently been explored (5) (6) (7) (8) (9) (10) (11) . In line with these attempts we here report nNOS as a crucial target gene of maternal TH in developing fetal cerebral cortex. nNOS catalyze the conversion of L-Arginine to L-Citrulline with production of nitric oxide (NO). Besides its role in regulating synaptic plasticity in the adult brain (24) (25) (26) , nitric oxide is known to regulate neurogenesis in both developing and adult brain (18, 19) . The anti-neurogenic action of nNOS is perhaps justified by its ontogenic appearance observed during brain development which marks the end of neurogenesis and a period of programmed cell death of postmitotic neurons (27) . The precocious upregulation of nNOS under maternal hypothyroidism and its association with decreased MAP-2 staining indicates defective neurogenesis in developing neo-cortex. Although nitric oxide inhibition of neurogenesis involves either mitotic arrest of NPC's (18) or increased death of the newly generated neurons (13, 19 ) the latter seems to be a more probable reason of decreased MAP-2 positivity under TH insufficiency as shown by increased PARP cleavage and TUNEL positivity. However, whether this loss of MAP-2 immunoreactivity is also a contribution of a maturation defects in cortical neurons still needs to be investigated. Unfortunately, inspite of the huge increase in the nNOS expression, we still don't know the mechanism by which maternal hypothyroidism bring about this increase. A strong possibility exist that the unliganded TR-α regulates nNOS levels at certain neurodevelopmental stages (ED14-18) under hypothyroidism.
Regulation of brain development by unliganded TH receptor are now well known (29, 30) and may have some implication in the premature onset of nNOS expression during neocortical development. However, whether such regulation of nNOS is purely genomic or also involves a non-genomic TH signaling as described for other NOS variants (31) will need further investigation. Moreover, whether TRs directly regulate nNOS expression or indirectly through repression of a putative nNOS transcriptional silencer also needs to be resolved. In this respect the appearance of nNOS at later stages under euthyroid condition could be due to following possible reasons (a) loss of this nNOS silencing mechanism during the progressive phase of neocortical development, (b) control of nNOS expression by other regulatory factor like neurotrophins and (c) alteration in TRs and their gene regulatory potential through changes in the levels of heterodimerization partners and transacting modulators of transcription. Understanding and answering these question will perhaps help us to resolve the paradox of whether TH deficiency per se or their unliganded receptors are detrimental for proper brain development (28) (29) (30) and whether the unliganded TRs act as "Dependence receptors" creating a state of dependence during developmental processes which may otherwise be independent of thyroid hormones (32) . Recent studies (4, 23, 33, 34) show that even a modest maternal T4 insufficiency during neocorticogenesis may result in serious anatomical and cognitive insults even if the maternal T3 and TSH are well maintained within the normal range. We extend support to these assertions and show that gene alteration in fetal brain from a hypothyroxinemic mother is as sensitive as that of a hypothyroid mother. Since maternal hypothyroxinemia is much more prevalent than hypothyroidism per se and is usually left undiagnosed in various societies (23, 35, 36) it warrants immediate attention and our study adds to this view with a molecular evidence showing a highly sensitive regulation of fetal nNOS by circulating maternal thyroxine. To conclude, this work complements the growing evidence for the indispensable role of maternal thyroxine in fetal brain development and supplements a molecular insight into its action in part through repressing the ontogenic induction of nNOS during embryonic neocortical development. 
Acknowledgement
